Parkinson Disease

Parkinson Disease Overview
Parkinson disease (PD) is an age-related deterioration of certain nerve systems, which affects your movement, balance, and muscle control.

Parkinson Disease
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, ...

What is Parkinson disease?
Parkinson disease is a progressive disorder of the nervous system. The disorder affects several regions of the brain, including an area called the substantia nigra that controls balance and movement.

PARKINSON DISEASE OVERVIEW
Parkinson disease (PD) is a common disorder that affects the brain's ability to control movement. More than 1 million people in North America have been diagnosed with PD, most of whom are greater than 60 years old.

Genetics of Parkinson disease: See: Parkinson disease gene.
Search All of MedicineNet For:
Privacy Policy ...

Parkinson Disease and Movement Disorders Clinic
top
What Do You Want To Do?

Parkinson Disease: The second most common neurodegenerative disorder. Caused by progressive loss of nerves in the central brain leading to tremors, slow, stiff movements, and other symptoms.

Parkinson disease
Definition Parkinson disease (PD) is a progressive movement disorder marked by tremors, rigidity, slow movements (bradykinesia), and posture instability.

Parkinson disease is characterized by a loss of neurons in the brain that release dopamine. This loss of dopamine causes the symptoms of the disease.

Unified Parkinson Disease Rating Scale (UPDRS): The UPDRS is the most commonly used to tool to rate the symptoms of Parkinson disease. This scale is intended to be used to follow the course of Parkinson disease in patients over a period of time.

American Parkinson Disease Association
The Michael J. Fox Foundation for Parkinson's Research
The National Parkinson Foundation
Parkinson's Disease Foundation
Parkinson's Institute ...

Familial Parkinson disease type 1A familial form of Parkinson disease inherited in an autosomal dominant manner due to mutation in the alpha-synuclein gene (SNCA) on chromosome 4q21. Also known as PARK1.

Juvenile Parkinson Disease
Juvenile Parkinson Disease, Autosomal Dominant
Juvenile Parkinson Disease, Autosomal Recessive ...

Drug treatments for Parkinson disease do not consistently control symptoms.

It is also used to treat the symptoms of Parkinson disease. Amantidine hydrochloride is a type of antiviral agent.
Permalink for amantadine hydrochloride
Ambien A drug used to treat insomnia (inability to sleep), and anxiety.

American Parkinson Disease Association, Inc. - Support Group
American Parkinson Disease Association, Inc. - Parkinson's Disease - Support Group
American Porphyria Foundation - Support Group ...

Parkinson disease 6, autosomal recessive early-onset (PARK6) ... anxiety
Parkinson disease 7, autosomal recessive, early-onset ... anxiety disorder
Parthenophobia ... feeling of panic, feeling of terror, anxiety, feeling of dread
Pathophobia ...

Dopa is used in the treatment of Parkinson disease. Parkinson disease is believed to be related to low levels of dopamine in certain parts of the brain. When dopa is taken by mouth, it crosses through the blood-brain barrier.

Pathological gambling caused by drugs used to treat Parkinson disease. Archives of Neurology. 2005;62:1377.
Unwin BK, et al. Pathologic gambling. American Family Physician. 2006;61(3):741.
Compulsive gambling.

- Statin use reduces Parkinson Disease risk
- Understanding working of parkin gene and Parkinson's disease
- Cognitive decline linked to brain volume decreases in parkinson's disease patients ...

5% to 1% of individuals undergoing thalamotomy die from bleeding into the brain; the procedure has a 9% to 23% chance of developing morbidity (Tagliati, "Parkinson Disease").

Biomarkers of Risk of Parkinson Disease
This study determines if people with risk factors for Parkinson's disease have biomarkers for the disease.
More Information »
See All Trials » ...

If you have PD, you may have a special assessment, called the Unified Parkinson Disease Rating Scale (UPDRS). This is generally done by a movement disorders neurologist while you are on your medications, then again when you are off them.

Practice Parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66:983-995.

Practice parameter: neuroprotective strategies and alternative therapies for parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006 Apr 11;66(7): 976-82.

American Parkinson Disease Association
National Parkinson Foundation, Inc.
Parkinson's Action Network
Parkinson's Support Groups of America (PSGA) " 301-937-1545
Worldwide Education and Awareness for Movement Disorders (WE MOVE) ...

Eskandar, Emad N., G. Rees Cosgrove, Leslie A. Shinobu. "Surgical Treatment of Parkinson Disease. (Contempo Updates Linking Evidence and Experience). " Journal of the American Medical Association 286 (December 26, 2001): 3056-3059.

Lewy bodies are deposits of protein in nerve cells, often deep within the brains of those who also have Parkinson Disease. When these protein deposits occur throughout the brain, dementia results.

When motor symptoms appear first and predominate over cognitive symptoms, the diagnosis is believed to be Parkinson disease. When cognitive impairment and behavioral disturbances are prominent early symptoms, DLB is believed to be the diagnosis.

With Parkinson's the incidence of RBD is increased and RBD may still precede the development of Parkinson's by several years. This relationship between RBD and Parkinson disease, however, ...

If shaking or trembling has been present for two or more years and you do not have an endocrine or hormonal imbalance, you may have essential tremor or Parkinson disease.
Signs, symptoms & indicators of Tremors:
Symptoms - Muscular ...

a unique encephalitis, presumably viral in origin, which followed the influenza pandemic of 1914-1918. Symptoms included ophthalmoplegia and marked somnolence, and in many survivors, the delayed development of Parkinson disease; ...

Gao X, Chen H, Fung TT, et al; Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007 Nov;86(5):1486-94. [abstract]
Scarmeas N, Luchsinger JA, Mayeux R, et al; Mediterranean diet and Alzheimer disease mortality.

[1,2,3] It has been promoted as an effective therapy for cancer and a wide range of other diseases including AIDS, collagen disease, lupus, scleroderma, cystic fibrosis, multiple sclerosis, adult-onset diabetes mellitus, emphysema, Parkinson disease, ...

Lewy bodya pink-staining sphere found in nerve cells, considered to be a pathological marker for Parkinson disease.

See also: Parkinson, Symptom, Sclerosis, Stroke, Cancer